Yoshihiro Ogawa

Active 1985–2025

304
Papers
44,367
Citations
120
h-index
293
i10-index

Citations

Citations per year for Yoshihiro Ogawa1978: 1 citations1985: 9 citations1986: 10 citations1987: 8 citations1988: 11 citations1989: 7 citations1990: 13 citations1991: 46 citations1992: 82 citations1993: 67 citations1994: 91 citations1995: 127 citations1996: 157 citations1997: 224 citations1998: 244 citations1999: 235 citations2000: 341 citations2001: 424 citations2002: 426 citations2003: 522 citations2004: 486 citations2005: 511 citations2006: 392 citations2007: 374 citations2008: 360 citations2009: 356 citations2010: 346 citations2011: 329 citations2012: 291 citations2013: 300 citations2014: 264 citations2015: 230 citations2016: 187 citations2017: 188 citations2018: 226 citations2019: 752 citations2020: 837 citations2021: 893 citations2022: 775 citations2023: 616 citations2024: 881 citations2025: 479 citations2026: 17 citations1979–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,693 citing papers, 25.7% of this breakdownJapan: 1,670 citing papers, 11.6% of this breakdownChina: 1,234 citing papers, 8.6% of this breakdownUnited Kingdom: 848 citing papers, 5.9% of this breakdownGermany: 695 citing papers, 4.8% of this breakdownItaly: 602 citing papers, 4.2% of this breakdownCanada: 489 citing papers, 3.4% of this breakdownFrance: 477 citing papers, 3.3% of this breakdownAustralia: 381 citing papers, 2.7% of this breakdownSpain: 345 citing papers, 2.4% of this breakdownNetherlands: 292 citing papers, 2% of this breakdownSouth Korea: 253 citing papers, 1.8% of this breakdown
0%25.7%Other 23.6%

Fields

  • Medicine57.1%
  • Neuroscience16.7%
  • Biochemistry, Genetics and Molecular Biology16.7%
  • Immunology and Microbiology3.3%
  • Nursing2.1%
  • Agricultural and Biological Sciences0.6%
  • Other3.5%

Topics

  • Regulation of Appetite and Obesity6.2%
  • Adipokines, Inflammation, and Metabolic Diseases5.4%
  • Adipose Tissue and Metabolism5.1%
  • Biochemical Analysis and Sensing Techniques3.1%
  • Liver Disease Diagnosis and Treatment2.1%
  • Heart Failure Treatment and Management2%
  • Other76.1%

Coauthors

All papers

Open in search
  1. Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial

    Authors: , , , , - The Lancet Diabetes & Endocrinology 2022 cited by 124

  2. Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Endocrine Journal 2022 cited by 212

  3. A Paracrine Loop Between Adipocytes and Macrophages Aggravates Inflammatory Changes

    Authors: , , - Arteriosclerosis Thrombosis and Vascular Biology 2005 cited by 1,031

  4. Hepatic Crown-Like Structure: A Unique Histological Feature in Non-Alcoholic Steatohepatitis in Mice and Humans

    Authors: , , , , , , , , , , , , , , , - PLoS ONE 2013 cited by 210

  5. Histone H3K36me2 and H3K36me3 form a chromatin platform essential for DNMT3A-dependent DNA methylation in mouse oocytes

    Authors: , , , , , , - Nature Communications 2022 cited by 98

  6. Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan

    Authors: , , , , , , , - Endocrine Journal 2023 cited by 159

  7. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , San‐e Ishikawa, Masafumi Kakei, Kazuyuki Namai, Naotake Hashimoto, Yoshifumi Suzuki, Shunichiro Onishi, Koutaro Yokote, Masafumi Matsuda, Masahiro Masuzawa, Yoichi Hayashi, Satoshi Saitô, Norikazu Ogihara, Hisamitsu Ishihara, Naoko Tajima, Kazunori Utsunomiya, Akira Shimada, Hiroshi Itoh, Ryuzo Kawamori, Hirotaka Watada, Michio Hayashi, Yasumichi Mori, Teruo Shiba, Akihiro Isogawa, Hiroshi Sakura, Masato Odawara, Kazuyuki Tobe, Kazuhisa Tsukamoto, Toshimasa Yamauchi, Tamio Teramoto, Yukio Hirata, Isao UCHIMURA, Yoshihiro Ogawa, Gen Yoshino, Takahisa Hirose, Hiroshi Kajio, Yoshihito Atsumi, Akira Shimada, Yoichi Oikawa, Atsushi Araki, Akio Ueki, Atsushi Ohno, Masafumi Kitaoka, Yoshikuni Fujita, Tatsumi Moriya, Taiki Tojo, Masayoshi Shichiri, Daisuke Suzuki, Masao Toyoda, Kumiko Hamano, Rieko Komi, Yasuo Terauchi, Nobuaki Kuzuya, Masayo Yamada, Toshinari Takamura, Mitsuo Imura, Hiroshi Tanaka, Masayuki Hayashi, Yasuhisa Kato, Mitsuyasu Itoh, Atsushi Suzuki, Mikihiro Nakayama, Takahisa Sano, Eitaro Nakashima, Yasuhiro Sumida, Yutaka Yano, Tsuyoshi Tanaka, Kazuya Murata, Atsunori Kashiwagi, Hiroshi Maegawa, Shigeo Kono and 57 more - The Lancet Diabetes & Endocrinology 2017 cited by 309

  8. Macrophage-inducible C-type lectin underlies obesity-induced adipose tissue fibrosis

    Authors: , , , , , , , , , , , , , , , - Nature Communications 2014 cited by 198

  9. Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH

    Authors: , , , , , , , , , , , - Scientific Reports 2018 cited by 175

  10. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study

    Authors: , , , , , , - Cardiovascular Diabetology 2018 cited by 122

  11. Role of the Toll-like Receptor 4/NF-κB Pathway in Saturated Fatty Acid–Induced Inflammatory Changes in the Interaction Between Adipocytes and Macrophages

    Authors: , , , , , , , , , , , - Arteriosclerosis Thrombosis and Vascular Biology 2006 cited by 804

  12. Lysosomal cholesterol overload in macrophages promotes liver fibrosis in a mouse model of NASH

    Authors: , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2023 cited by 47

  13. Synthetic “smart gel” provides glucose-responsive insulin delivery in diabetic mice

    Authors: , , , , , , , , , , , , , - Science Advances 2017 cited by 162

  14. Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study

    Authors: , , , , , , , , , , , , - Cardiovascular Diabetology 2017 cited by 173

  15. Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction

    Authors: , , , , , , , , - PLoS ONE 2016 cited by 229

  16. Adipose tissue inflammation and ectopic lipid accumulation [Review]

    Authors: , , - Endocrine Journal 2012 cited by 199

  17. Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shozo Miyauchi, Tomikazu Fukuoka, Shoichiro Izawa, Takashi Yoneda, Shigeatsu Hashimoto, Toshihiko Yanase, Tomoko Suzuki, Takashi Kawamura, Yasuharu Tabara, Fumihiko Matsuda, Mitsuhide Naruse, Nagahama Study*, Takahisa Kawaguchi, Kazuya Setoh, Fumihiko Matsuda, Yoshimitsu Takahashi, Takeo Nakayama, Shinji Kosugi - Hypertension 2018 cited by 199

  18. FOXO1 cooperates with C/EBPδ and ATF4 to regulate skeletal muscle atrophy transcriptional program during fasting

    Authors: , , , , , , , , , , , , , - The FASEB Journal 2022 cited by 57

  19. Mucosa-associated gut microbiota reflects clinical course of ulcerative colitis

    Authors: , , , , , , , , , , - Scientific Reports 2021 cited by 57

  20. Melanocortin 4 Receptor–Deficient Mice as a Novel Mouse Model of Nonalcoholic Steatohepatitis

    Authors: , , , , , , , , - American Journal Of Pathology 2011 cited by 163

  21. Activating Transcription Factor 4 Links Metabolic Stress to Interleukin-6 Expression in Macrophages

    Authors: , , , , , , , , , , - Diabetes 2013 cited by 137

  22. Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study

    Authors: , , , , , , , , , , , , - Diabetes Therapy 2017 cited by 124

  23. Human leucocyte antigen DR15, a possible predictive marker for immune checkpoint inhibitor–induced secondary adrenal insufficiency

    Authors: , , , , , , , , , , , , , , , - European Journal of Cancer 2020 cited by 90

  24. CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis

    Authors: , , , , , , , , , , , , , , , - JCI Insight 2017 cited by 88